OCX - OncoCyte GAAP EPS of -$1.03 beats by $0.21 revenue of $0.46M beats by $0.11M
2023-08-10 07:05:33 ET
- OncoCyte press release ( NASDAQ: OCX ): Q2 GAAP EPS of -$1.03 beats by $0.21 .
- Revenue of $0.46M (+91.7% Y/Y) beats by $0.11M .
- Cash, cash equivalents, and marketable securities totaled $17.9 million at June 30, 2023, with average cash burn projected to drop below $5 million a quarter in 2 H HH 2023
For further details see:
OncoCyte GAAP EPS of -$1.03 beats by $0.21, revenue of $0.46M beats by $0.11M